(19)
(11) EP 0 817 778 A1

(12)

(43) Date of publication:
14.01.1998 Bulletin 1998/03

(21) Application number: 96910499.0

(22) Date of filing: 21.03.1996
(51) International Patent Classification (IPC): 
C07D 295/ 20( . )
A61K 31/ 535( . )
A61P 43/ 00( . )
C07C 237/ 22( . )
C07D 213/ 72( . )
C07F 7/ 10( . )
C07K 5/ 087( . )
C07K 14/ 81( . )
A61K 31/ 44( . )
A61K 31/ 5375( . )
C07C 231/ 02( . )
C07C 317/ 28( . )
C07D 295/ 215( . )
C07F 9/ 6533( . )
C07K 5/ 107( . )
A61K 38/ 00( . )
(86) International application number:
PCT/US1996/003844
(87) International publication number:
WO 1996/030353 (03.10.1996 Gazette 1996/44)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 24.03.1995 US 19950409996

(71) Applicant: ARRIS PHARMACEUTICAL CORPORATION
South San Francisco, CA 94080 (US)

(72) Inventors:
  • PALMER, James, T.
    San Ramon, CA 94583 (US)
  • RASNICK, David
    San Francisco, CA 94110 (US)
  • KLAUS, Jeffrey, L.
    Burlingame, CA 94010 (US)

(74) Representative: Baldock, Sharon Claire, et al 
BOULT WADE TENNANT, 27 Furnival Street
London EC4A 1PQ
London EC4A 1PQ (GB)

   


(54) REVERSIBLE PROTEASE INHIBITORS